These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32742132)

  • 1. Functionality is not an independent prognostic factor for pancreatic neuroendocrine tumors.
    Chen HY; Zhou YL; Chen YH; Wang X; Zhang H; Ke NW; Liu XB; Tan CL
    World J Gastroenterol; 2020 Jul; 26(25):3638-3649. PubMed ID: 32742132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic neuroendocrine tumours: Grade is superior to T, N, or M status in predicting outcome and selecting patients for chemotherapy:A retrospective cohort study in the SEER database.
    Zhai H; Li D; Feng Q; Qian X; Li L; Yao J
    Int J Surg; 2019 Jun; 66():103-109. PubMed ID: 30872175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological Characteristics of Nonfunctional Pancreatic Neuroendocrine Neoplasms and the Effect of Surgical Treatment on the Prognosis of Patients with Liver Metastases: A Study Based on the SEER Database.
    Sadula A; Li G; Xiu D; Ye C; Ren S; Guo X; Yuan C
    Comput Math Methods Med; 2022; 2022():3689895. PubMed ID: 35720036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis analysis of patients with pancreatic neuroendocrine tumors after surgical resection and the application of enucleation.
    Chen J; Yang Y; Liu Y; Kan H
    World J Surg Oncol; 2021 Jan; 19(1):11. PubMed ID: 33436017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival.
    Halfdanarson TR; Rabe KG; Rubin J; Petersen GM
    Ann Oncol; 2008 Oct; 19(10):1727-33. PubMed ID: 18515795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics and Prognostic Factors of Early-Onset Pancreatic Neuroendocrine Tumors.
    Shi M; Zhou B
    Cancer Control; 2021; 28():1073274820986827. PubMed ID: 33491476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study.
    Cai JS; Chen HY; Lu YF; Yu RS
    Future Oncol; 2020 Jan; 16(2):4369-4379. PubMed ID: 31802701
    [No Abstract]   [Full Text] [Related]  

  • 8. A wait-and-watch approach to small pancreatic neuroendocrine tumors: prognosis and survival.
    Massironi S; Rossi RE; Zilli A; Casazza G; Ciafardini C; Conte D
    Oncotarget; 2016 Apr; 7(14):18978-83. PubMed ID: 26959887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characteristics, survival outcomes and prognostic factors in the cT1N0M0 pancreatic neuroendocrine tumors: A SEER-based study.
    Guo N; Liang Z; Xiong LJ
    Medicine (Baltimore); 2022 Oct; 101(41):e31019. PubMed ID: 36254020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences and Similarities in the Clinicopathological Features of Pancreatic Neuroendocrine Tumors in China and the United States: A Multicenter Study.
    Zhu LM; Tang L; Qiao XW; Wolin E; Nissen NN; Dhall D; Chen J; Shen L; Chi Y; Yuan YZ; Ben QW; Lv B; Zhou YR; Bai CM; Chen J; Song YL; Song TT; Lu CM; Yu R; Chen YJ
    Medicine (Baltimore); 2016 Feb; 95(7):e2836. PubMed ID: 26886644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases.
    Ye L; Ye H; Zhou Q; Li Z; Lin Q; Tan L; Gao W; Fu Z; Zheng S; Chen R
    Int J Surg; 2016 May; 29():108-17. PubMed ID: 27000717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China.
    Fang C; Wang W; Zhang Y; Feng X; Sun J; Zeng Y; Chen Y; Li Y; Chen M; Zhou Z; Chen J
    Chin J Cancer; 2017 Jun; 36(1):51. PubMed ID: 28637502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical resection of primary tumor is associated with prolonged survival in low-grade pancreatic neuroendocrine tumors.
    Sun Y; Wang Y; Li R; Kang G; Zhang M; Chen X; Jin M; Liu Y; He Y; Zhu X; Kang Q; Zhou F; Yu Q
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101432. PubMed ID: 32386797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-level analysis of pancreatic neuroendocrine tumors 2 cm or less in size.
    Kuo EJ; Salem RR
    Ann Surg Oncol; 2013 Sep; 20(9):2815-21. PubMed ID: 23771245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors.
    Zhou B; Fang B; Yan S; Wang W
    Clin Lab; 2017 Jul; 63(7):1251-1259. PubMed ID: 28792692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrinsic Contact Between T and N Classifications in Resected Well-Moderately Differentiated Locoregional Pancreatic Neuroendocrine Neoplasms.
    Xu JZ; Wang WQ; Zhang SR; Xu HX; Wu CT; Qi ZH; Gao HL; Ni QX; Liu L; Yu XJ
    Ann Surg Oncol; 2018 Mar; 25(3):647-654. PubMed ID: 29235006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of clinical characteristics and prognosis of 235 pancreatic neuroendocrine tumors underwent Sunitinib treatment].
    Xu JM; Cui HT; Jia R; Zhao CH; Zhao P
    Zhonghua Zhong Liu Za Zhi; 2021 Mar; 43(3):324-328. PubMed ID: 33752313
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical outcome and long-term survival of 150 consecutive patients with pancreatic neuroendocrine tumors: A comprehensive analysis by the World Health Organization 2010 grading classification.
    Deng BY; Liu F; Yin SN; Chen AP; Xu L; Li B
    Clin Res Hepatol Gastroenterol; 2018 Jun; 42(3):261-268. PubMed ID: 29307515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Demographics, Tumor Characteristics, and Survival Between Pancreatic Adenocarcinomas and Pancreatic Neuroendocrine Tumors: A Population-based Study.
    Yadav S; Sharma P; Zakalik D
    Am J Clin Oncol; 2018 May; 41(5):485-491. PubMed ID: 27322698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States.
    Liu X; Chen B; Chen J; Su Z; Sun S
    J Endocrinol Invest; 2023 Jul; 46(7):1373-1384. PubMed ID: 36522587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.